$APH

D'AMICO LANCE E sold $8.1M of APH

D'AMICO LANCE E (EVP, Secretary & GenCounsel) sold 50,000 shares of AMPHENOL CORP /DE/ (APH) at $161.99 ($8.10M total) on 2026-08-03.

Original reporting
SEC EDGAR · D'AMICO LANCE E
Published Aug 5, 2026, 4:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 6, 2026, 6:25 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$APH
Neutral
medium confidence
Mentioned
$APH
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$APHNeutralLow
01

Why it matters

The newest fact is the disclosed open-market sale amount, share count, and execution price, which can marginally affect sentiment but does not change company fundamentals.

02

Market read

Traders may note the insider sale size and timing, but there is no accompanying guidance, deal, or regulatory development.

03

What to watch

The transaction is not stated as part of a 10b5-1 plan, but the filing alone does not reveal intent, option exercises, or other concurrent insider activity.

Relevance 6/10Novelty 3/10Timing: Form 4 filed 2026-08-05, covering a sale executed 2026-08-03.

Background

The article is an SEC Form 4 insider transaction disclosure for Amphenol (APH).

Company-level read

Ticker impact

$APHNeutralMedium confidence
Context

Amphenol insider D'Amico sold 50,000 shares on 2026-08-03 at $161.9874, totaling about $8.1M, per Form 4 filed 2026-08-05.

Expected impact

Likely minimal near-term impact; any effect would be sentiment-driven and short-lived.

Evidence & confidence

The filing discloses transaction size and price, but provides no new company fundamentals, guidance, or operational/regulatory catalyst.

Market effects

No clear sector read-through; insider sales are common and typically not sector-moving without accompanying fundamentals.

None indicated.

None indicated.

Counterpoint

The sale could be for diversification, taxes, or pre-existing personal liquidity needs, so it may not reflect bearish views on Amphenol’s outlook.

Key entities

  • AMPHENOL CORP /DE/

    Company whose insider transaction is disclosed on Form 4.

  • D'AMICO LANCE E

    EVP, Secretary & GenCounsel who sold 50,000 shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$APHMed

Why Amphenol Stock Topped the Market on Tuesday

Amphenol (NYSE: APH) shares rose 1.6% on Tuesday, outperforming the S&P 500, after two analysts raised their price targets. Goldman Sachs increased its target to $116, while Baird raised it to $105. Both maintained buy ratings, citing Amphenol's role in supplying components for AI data centers.

$TTMIMed

Soaring Defense Spending Means Great News for These 2 Stocks

TTM Technologies (TTMI) and Amphenol (APH) have seen significant stock gains this year due to increased defense spending. TTM reported Q2 revenue of $1B (+37% YoY) and EPS of $0.77 (+92.5% YoY). Amphenol reported Q2 revenue of $8.8B (+55% YoY) and EPS of $1.37 (+59% YoY). Both companies benefit from defense electronics supply chain and AI infrastructure surges. They also have other revenue streams, with AI data center spending contributing significantly.

$APHMedAI 8/10

APH's AI Datacom Strength Grows: Can It Challenge TEL & MRVL?

Amphenol (APH) reported strong Q2 2026 results, with IT datacom sales up 89% YoY, driven by AI-related demand. AI revenue run rate reached $10.5-$11B. CommScope acquisition added $1.2B in sales. Competitors TEL and MRVL also reported growth in AI-related segments. APH stock up 16% YTD, trading at 25.32x forward P/E. Earnings estimates revised up to 72 cents per share.

$APHMed

APH Looks 5.7% Overvalued on GF Value™

Citi analyst Asiya Merchant initiated a 90-day catalyst watch on Amphenol Corp (APH), maintaining a Buy rating with a $105 target price. The firm cited benefits from AI and data center investments. APH is trading at $83.92, 5.7% above its GF Value™ of $79.43, indicating slight overvaluation. The company has a GF Score™ of 97/100, reflecting strong profitability and growth. Insider activity shows net selling over the past 12 months.

$APHMedAI 8/10

Is Amphenol Stock Outperforming the Dow?

Amphenol (APH) stock is down 18.3% from its 52-week high but up 46.5% over the past year, outperforming the Dow. Q2 2026 revenue rose 55% to $8.8B, beating estimates. Analysts rate it a 'Strong Buy' with a $200.50 price target. APH trades above its 200-day but below its 50-day moving average.